| 809285-09-4 | Tamoxifen EP Impurity H |
| 1334162-51-4 | S-Adenosyl-L-Methionine Impurity 1 |
| 1391194-63-0 | Phenylephrine Impurity 10 |
| 1452166-70-9 | Nilvadipine Impurity 1 |
| 714192-43-5 | Mivacurium Chloride Impurity 4 |
| 982-89-8 | Megestrol acetate EP Impurity E |
| 382137-78-2 | [1,1':3',1''-Terphenyl]-4,4''-dicarbonitrile, 5'-(4-cyanophenyl)- |
| 144562-61-8 | E-6700 |
| 732278-52-3 | BDZ-g,GYKI 47409, |
| 68423-22-3 | Spiro[2.2]pentan-1-ol |
| 1421312-32-4 | methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate |
| 34199-54-7 | 2-(3,4,5-tribromo-pyrazol-1-yl)-hexanoic acid ethyl ester, ethyl 3,4,5-tribromo-α-butylpyrazole-1-acetate, ethyl 3,4,5-tribromo-α-butylpyrazole-1-acetate |
| 42459-30-3 | Lidocaine EP Impurity G |
| 1898283-02-7 | 2-(4-((4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridin-2-yl)amino)pyridin-2-yl)propan-2-ol |
| 56000-23-8 | tetrahydro-1H-cyclopenta[c]furan-5(3H)-one |
| 1300735-41-4 | GSK1210151A S isomer |
| 1400987-00-9 | [1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl]-4,4''''-diamine, 5''-(4'-amino[1,1'-biphenyl]-4-yl)- |
| 895542-09-3 | Trifarotene |
| 2005454-12-4 | PD1 Inhbitor, Aurigene Cmpd 16 |
| 1510796-68-5 | (S) enantiomer racemates CAS:1429192-00-6 |
| 81623-66-7 | (S)-1,2-Epoxydecane |
| 1516903-65-3 | BDZ-h,GYKI 47654 |
| 2091134-68-6 | AZD-4205 |
| 22478-60-0 | 1-Phenanthrenamine,1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aS,10aR)- |
| 364067-22-1 | Cindunistat ,PF-00572986
PHA-84250 |
| 1891087-61-8 | BAY-1816032 |
| 933686-09-0 | 4,6-Dichloro-2-methyl-5-pyrimidinecarboxylic acid |
| 1330782-76-7 | TAK-931 |
| 2055536-64-4 | LYC-55716 |
| 1844849-11-1 | PF-06821497 |
| 1425381-60-7 | Gusacitinib |
| 133810-39-6 | 5-Ethynyl-1,10-phenanthroline |
| 1276666-19-3 | Suvorexant Impurity 2 |
| 1021431-39-9 | (4-(benzyloxy)-2-formyl-5-methoxyphenyl)boronic acid |
| 6142-68-3 | Spiro[2.2]pentane-1-carboxylic acid, ethyl ester |
| 1883265-29-9 | 2-(6-((cyclopropylmethyl)carbamoyl)-2-(methoxycarbonyl)pyridin-3-yl)-4-methoxy-5-vinylbenzoic acid |
| 1506601-94-0 | Spiro[2.2]pentane-1-methanamine |
| 1321517-59-2 | 6-bromo-5-(4-fluorophenyl)-1,2,4-triazin-3-amine |
| 207459-15-2 | benzyl 4-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate |
| 1616967-26-0 | Formoterol EP Impurity E |
| 1346599-85-6 | Esomeprazole Impurity 3 |
| 869485-36-9 | Dirithromycin EP impurity B |
| 1809224-82-5 | Dexamethasone EP Impurity K |
| 98924-69-7 | Creatine Phosphate Impurity 1 |
| 96680-30-7 | Cefpodoxime Proxetil EP Impurity F |
| 122152-13-0 | Butenafine Impurity 3 |
| 1883265-20-0 | 2-Pyridinecarboxylic acid, 6-[[(cyclopropylmethyl)amino]carbonyl]-3-methoxy-, methyl ester |
| 2089288-03-7 | AZD-1390 |
| 1262050-69-0 | 2,3,7-tribromo-9H-pyrazolo[5,1-b][1,3]benzoxazine |
| 279236-52-1 | 2-(1-carbamoylpiperidin-4-yl)acetic acid |
| 755030-94-5 | 2-methoxy-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile |
| 33447-49-3 | Spiro[2.2]pentane-1-carboxylic acid, methyl ester |
| 949145-30-6 | 3-amino-6-bromo-2-methylbenzoic acid |
| 1222084-56-1 | (2-Methyloxazol-5-yl)methanamine hydrochloride |
| 1427440-20-7 | Methyl 4-amino-2-bromo-5-chlorobenzoate |
| 1240595-01-0 | Methyl 4,5-dichloropyrmidine-2-carboxylate |
| 54708-12-2 | N-(2,6-dimethylphenyl)thiazol-2-amine |
| 926927-57-3 | (lE,4E)-ethyl 8-bromo-2-(tert-butoxycarbonylamino)-3H-benzo[b]azepine-4-carboxylate |
| 920112-97-6 | ((2R,3S)-1-methyl-3-(2,4,6-trimethoxyphenyl)pyrrolidin-2-yl)methanol |
| 1809278-99-6 | Tianeptine intermediate |
| 60184-65-8 | 1H-pyrazole-3,4,5-tricarboxylate |
| 90510-39-7 | Tocopherol Impurity 2 |
| 1345822-88-9 | Sitagliptin Impurity 7 |
| 97900-87-3 | Roxatidine Acetate Impurity 2 |
| 1147937-31-2 | Pramipexole Dimer Impurity (Mixture of Diastereomers) |
| 1388148-29-5 | Posaconazole Impurity 47 |
| 330157-04-5 | Betamethasone EP Impurity F |
| 1802552-31-3 | Bazedoxifene impurity 8 |
| 94975-84-5 | Argatroban Impurity 13 |
| 183664-56-4 | Aprepitant Impurity 13 |
| 1279049-53-4 | Alfacalcidol |
| 1700608-88-3 | :2-Morpholinecarboxamide,4-(8-cyano-5-quinolinyl)-N-((3S,4R) -4- fluoro-3-pyrrolidinyl)-6-methyl-, hydrochloride (1:1), (2R,6R)- |
| 1246466-56-7 | 5,6-Bis(trifluoromethyl)pyridin-2-amine |
| 31785-64-5 | Lidocaine EP Impurity |
| 84485-08-5 | Chloro-Sibutramine HCl |
| 6979-81-3 | Bortezomib Impurity H |
| 1584730-02-8 | Azilsartan Impurity 25 |
| 1333998-27-8 | Aprepitant Impurity 17 |
| 1651828-04-4 | Aprepitant Impurity 10 |
| 58256-09-0 | 5-(α-naphthyl)thiophene-2-carbaldehyde |
| 34157-42-1 | (3,4,5-tribromo-pyrazol-1-yl)-acetic acid ethyl ester |
| 81262-69-3 | 3,4-Methylenedioxy-N-methylphentermine |
| 216454-90-9 | 9,9-dimethyl-9H-fluorene-2,7-diamine |
| 242129-35-7 | 5-Acroyloxy-2,6-norbornane carbolactone |
| 852246-52-7 | 2-Methyl-α-[2-[[[(4-methylphenyl)sulfonyl]oxy]imino]-3(2H)-thienylidene]benzeneacetonitrile |
| 895156-63-5 | 2,5-Bis-(4-aminophenyl)pyridine |
| 1091585-25-9 | {(2R,5S) 5 [4 ACETAMIDO 2 OXO 1(2H) PYRIMIDINYL] 1,3 OXATHIOLAN 2 YL}METHYL MENTHYL CARBONATE |
| 243145-00-8 | Vildagliptin Impurity 19 |
| 1310803-27-0 | Sulfasalazine EP Impurity I |
| 2072867-07-1 | Sitagliptin Impurity 14 |
| 1496712-39-0 | Saxagliptin Impurity 15 |
| 123185-88-6 | Rosuvastatin Impurity 32 |
| 94670-39-0 | Rebamipide Impurity 1 |
| 63235-39-2 | Procaterol Impurity 4 |
| 2635-64-5 | Pomalidomide Impurity 3 |
| 17332-34-2 | Polaprezinc Impurity 2 |
| 1819364-05-0 | Omarigliptin Impurity 12 |
| 1445990-09-9 | Nifuratel Impurity 4 |
| 903563-43-9 | N-(5-Formyl-2-hydroxyphenyl)formamide |
| 733704-04-6 | Mivacurium Chloride Impurity 1 |